Inventor · disambiguated record
Shoji Furusako
Also filed as: FURUSAKO SHOJI
17 granted patents·16 pending applications·236 citations·filing 1995–2024
93Inventor score
Top patents by PatentIndex Score
33 records- 0195US11932708B2Crosslinked alginic acidMOCHIDA PHARM CO LTD·Filed 2020·Granted Mar 19, 2024·5 cites·16 claims
- 0293US12312574B2Polymer-coated crosslinked alginate gel fiberMOCHIDA PHARM CO LTD·Filed 2023·Granted May 27, 2025·2 cites·20 claims
- 0391US7977461B2Anti-platelet membrane glycoprotein VI monoclonal antibodyMOCHIDA PHARM CO LTD·Filed 2006·Granted Jul 12, 2011·18 cites·9 claims
- 0490US8252905B2Anti-CD14 antibody fusion proteinFURUSAKO SHOJI·Filed 2006·Granted Aug 28, 2012·16 cites·53 claims
- 0590US6423489B1Compositions and methods for treatment of Hepatitis C virus-associated diseasesISIS PHARMACEUTICALS INC·Filed 1995·Granted Jul 23, 2002·120 cites·7 claims
- 0686US8389692B2Anti-platelet membrane glycoprotein VI monoclonal antibodyTAKAYAMA HIROSHI·Filed 2011·Granted Mar 5, 2013·8 cites·8 claims
- 0786US7608684B2Soluble CD14 antigenMOCHIDA PHARM CO LTD·Filed 2005·Granted Oct 27, 2009·12 cites·12 claims
- 0885US8124722B2Soluble CD14 antigenFURUSAKO SHOJI·Filed 2009·Granted Feb 28, 2012·9 cites·2 claims
- 0984US7901900B2Assay kit and antibody for human low molecular weight CD14MOCHIDA PHARM CO LTD·Filed 2007·Granted Mar 8, 2011·6 cites·5 claims
- 1078US2024174772A1Novel crosslinked alginic acidMOCHIDA PHARM CO LTD·Filed 2024·Application pending·0 cites
- 1174US8524870B2Anti-platelet membrane glycoprotein VI monoclonal antibodyMOCHIDA PHARM CO LTD·Filed 2012·Granted Sep 3, 2013·1 cites·8 claims
- 1271US6251873B1Antisense compounds to CD14MOCHIDA PHARM CO LTD·Filed 1998·Granted Jun 26, 2001·30 cites·20 claims
- 1370US7465547B2Methods for detecting human low molecular weight CD14MOCHIDA PHARM CO LTD·Filed 2003·Granted Dec 16, 2008·7 cites·8 claims
- 1467US2023190943A1Alginic acid derivative bonded to nonsteroidal anti-inflammatory compoundMOCHIDA PHARM CO LTD·Filed 2023·Application pending·0 cites
- 1565US7264967B2Anti-CD14 monoclonal antibody having effect of inhibiting CD14/TLR bindingMOCHIDA PHARM CO LTD·Filed 2001·Granted Sep 4, 2007·2 cites·15 claims
- 1664US2023035986A1Novel crosslinked alginic acidMOCHIDA PHARM CO LTD·Filed 2022·Application pending·0 cites
- 1763US2025376792A1Gel fiber manufacturing apparatus and manufacturing methodMOCHIDA PHARM CO LTD·Filed 2023·Application pending·0 cites
- 1862US2014044723A1Anti-platelet membrane glycoprotein vi monoclonal antibodyMOCHIDA PHARM CO LTD·Filed 2013·Application pending·0 cites
- 1960US2024132854A1Novel multilayer polymer-coated crosslinked alginate gel fiberMOCHIDA PHARM CO LTD·Filed 2021·Application pending·0 cites
- 2060US2024342340A1Multilayer structure using chemically crosslinked alginic acidMOCHIDA PHARM CO LTD·Filed 2021·Application pending·0 cites
- 2159US2009041783A1Anti-platelet membrane glycoprotein vi monoclonal antibodyMOCHIDA PHARM CO LTD·Filed 2006·Application pending·0 cites
- 2256US11472892B2Reactive alginic acid derivativesMOCHIDA PHARM CO LTD·Filed 2019·Granted Oct 18, 2022·0 cites·20 claims
- 2356US8541565B2Polynucleotide encoding anti-CD14 antibody fusion proteinFURUSAKO SHOJI·Filed 2012·Granted Sep 24, 2013·0 cites·30 claims
- 2456US2021000968A1Alginic acid derivative bonded to nonsteroidal anti-inflammatory compoundMOCHIDA PHARM CO LTD·Filed 2020·Application pending·0 cites
- 2555US2014050727A1Anti-cd14 antibody fusion proteinMOCHIDA PHARM CO LTD·Filed 2013·Application pending·0 cites
- 2655US2021340481A1Alginate hollow microfiberMOCHIDA PHARM CO LTD·Filed 2019·Application pending·0 cites
- 2752US2024316248A1Transplantation device using chemically crosslinked alginic acidMOCHIDA PHARM CO LTD·Filed 2020·Application pending·0 cites
- 2851US12479933B2Crosslinked alginic acid structureMOCHIDA PHARM CO LTD·Filed 2020·Granted Nov 25, 2025·0 cites·14 claims
- 2951US11472891B2Photocrosslinkable alginic acid derivativeMOCHIDA PHARM CO LTD·Filed 2019·Granted Oct 18, 2022·0 cites·27 claims
- 3045US2022409773A1Transplantation device using chemically crosslinked alginic acidMOCHIDA PHARM CO LTD·Filed 2020·Application pending·0 cites
- 3144US2004092712A1Tlr/cd14 binding inhibitorFiled 2001·Application pending·0 cites
- 3239US2004234978A1Novel potential-dependent cation channel proteinFiled 2002·Application pending·0 cites
- 3337US2004076986A1Novel atopic dermatitis-associated gene and proteinsFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shoji Furusako files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →